Top

22-02-2015 | Gynecologic cancers | Article

Modern radiation therapy and potential fertility preservation strategies in patients with cervical cancer undergoing chemoradiation

Journal: Radiation Oncology

Authors: Pirus Ghadjar, Volker Budach, Christhardt Köhler, Andreas Jantke, Simone Marnitz

Publisher: BioMed Central

Abstract

Young patients with cervical cancer who undergo chemoradiation might be interested in fertility preservation, not only dependent upon the use of a gestational carrier as maybe achieved by the use of ovarian transposition and cryo-conservation of oocytes or ovarian tissue, but may prefer to carry pregnancy to term after cancer treatment. The latter approach is a non-established concept needing both modern radiation therapy approaches as well as modifications -if at all possible- in current recommendations for target volume delineation to spare dose to the unaffected uterus. Future strategies to serve selected patients in this respect should only be conducted in prospective clinical evaluations and are critically discussed in this article.

Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.CrossRefPubMed

Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr 2005:64–68.

Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys. 2009;73:1304–12.CrossRefPubMedCentralPubMed

Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992;7:1342–6.PubMed

Gross E, Champetier C, Pointreau Y, Zaccariotto A, Dubergé T, Guerder C, et al. Normal tissue tolerance to external beam radiation therapy: ovaries. Cancer Radiother. 2010;14:373–5.CrossRefPubMed

Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18:117–21.CrossRefPubMed

Oncology RotJCfC. Management of Gonadal Toxicity Resulting from the Treatment of Adult Cancer. 1998. ISBN 1 86016 071 9.

Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006;91:1723–8.CrossRefPubMed

Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol. 2005;23:3858–9.CrossRefPubMed

10.

Han SS, Kim YH, Lee SH, Kim GJ, Kim HJ, Kim JW, et al. Underuse of ovarian transposition in reproductive-aged cancer patients treated by primary or adjuvant pelvic irradiation. J Obstet Gynaecol Res. 2011;37:825–9.CrossRefPubMed

11.

Anderson RAWW. Fertility preservation in girls and young females. Clin Endocrinol (Oxf). 2011;75:409–19.CrossRef

12.

Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405–10.CrossRefPubMed

13.

Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–31.CrossRefPubMed

14.

Dittrich R, Lotz L, Keck G, Hoffmann I, Mueller A, Beckmann MW, et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril. 2012;97:387–90.CrossRefPubMed

15.

Kim SS, Hwang IT, Lee HC. Heterotopic autotransplantation of cryobanked human ovarian tissue as a strategy to restore ovarian function. Fertil Steril. 2004;82:930–2.CrossRefPubMed

16.

Kim SS. Assessment of long term endocrine function after transplantation of frozen-thawed human ovarian tissue to the heterotopic site: 10 year longitudinal follow-up study. J Assist Reprod Genet. 2012;29:489–93.CrossRefPubMedCentralPubMed

17.

Clough KB, Goffinet F, Labib A, Renolleau C, Campana F, de la Rochefordiere A, et al. Laparoscopic unilateral ovarian transposition prior to irradiation: prospective study of 20 cases. Cancer. 1996;77:2638–45.CrossRefPubMed

18.

Hwang JH, Yoo HJ, Park SH, Lim MC, Seo SS, Kang S, et al. Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy. Fertil Steril. 2012;97:1387–93. e1381-1382.CrossRefPubMed

19.

Morice P, Juncker L, Rey A, El-Hassan J, Haie-Meder C, Castaigne D. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril. 2000;74:743–8.CrossRefPubMed

20.

Iavazzo C, Darlas FM, Gkegkes ID. The role of robotics in ovarian transposition. Acta Inform Med. 2013;21:135–7.CrossRefPubMedCentralPubMed

21.

Gallocher O, Thomas L, Stockle E, Bussières E, Floquet A, Avril A, et al. First surgery followed by vaginal curietherapy in small-volume uterine cervix cancer: an alternative to the association of uterovaginalcurietherapy and surgery. Cancer Radiother. 2002;6:10–4.CrossRefPubMed

22.

Barahmeh S, Al Masri M, Badran O, Masarweh M, El-Ghanem M, Jaradat I, et al. Ovarian transposition before pelvic irradiation: indications and functional outcome. J Obstet Gynaecol Res. 2013;39:1533–7.CrossRefPubMed

23.

Olejek A, Wala D, Chimiczewski P, Rzempoluch J. Hormonal activity of transposed ovaries in young women treated for cervical cancer. Gynecol Endocrinol. 2001;15:5–13.CrossRefPubMed

24.

Huang KG, Lee CL, Tsai CS, Han CM, Hwang LL. A new approach for laparoscopic ovarian transposition before pelvic irradiation. Gynecol Oncol. 2007;105:234–7.CrossRefPubMed

25.

Ishii K, Aoki Y, Takakuwa K, Tanaka K. Ovarian function after radical hysterectomy with ovarian preservation for cervical cancer. J Reprod Med. 2001;46:347–52.PubMed

26.

Pahisa J, Martinez-Roman S, Martinez-Zamora MA, Torné A, Caparrós X, Sanjuán A, et al. Laparoscopic ovarian transposition in patients with early cervical cancer. Int J Gynecol Cancer. 2008;18:584–9.CrossRefPubMed

27.

Giacalone PL, Laffargue F, Benos P, Dechaud H, Hédon B. Successful in vitro fertilization-surrogate pregnancy in a patient with ovarian transposition who had undergone chemotherapy and pelvic irradiation. Fertil Steril. 2001;76:388–9.CrossRefPubMed

28.

Zinger M, Liu JH, Husseinzadeh N, Thomas MA. Successful surrogate pregnancy after ovarian transposition, pelvic irradiation and hysterectomy. J Reprod Med. 2004;49:573–4.PubMed

29.

Agorastos T, Zafrakas M, Mastrominas M. Long-term follow-up after cervical cancer treatment and subsequent successful surrogate pregnancy. Reprod Biomed Online. 2009;19:250–1.CrossRefPubMed

30.

Delotte J, Ferron G, Kuei TL, Mery E, Gladieff L, Querleu D. Laparoscopic management of an isolated ovarian metastasis on a transposed ovary in a patient treated for stage IB1 adenocarcinoma of the cervix. J Minim Invasive Gynecol. 2009;16:106–8.CrossRefPubMed

31.

Shigematsu T, Ohishi Y, Fujita T, Higashihara J, Irie T, Hayashi T. Metastatic carcinoma in a transposed ovary after radical hysterectomy for a stage 1B cervical adenosquamous cell carcinoma. Case report. Eur J Gynaecol Oncol. 2000;21:383–6.PubMed

32.

Morice P, Haie-Meder C, Pautier P, Lhomme C, Castaigne D. Ovarian metastasis on transposed ovary in patients treated for squamous cell carcinoma of the uterine cervix: report of two cases and surgical implications. Gynecol Oncol. 2001;83:605–7.CrossRefPubMed

33.

Zhao C, Wang JL, Wang SJ, Zhao LJ, Wei LH. Analysis of the risk factors for the recurrence of cervical cancer following ovarian transposition. Eur J Gynaecol Oncol. 2013;34:124–7.PubMed

34.

Nakanishi T, Wakai K, Ishikawa H, Nawa A, Suzuki Y, Nakamura S, et al. A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol. 2001;82:504–9.CrossRefPubMed

35.

Shimada M, Kigawa J, Nishimura R, Yamaguchi S, Kuzuya K, Nakanishi T, et al. Ovarian metastasis in carcinoma of the uterine cervix. Gynecol Oncol. 2006;101:234–7.CrossRefPubMed

36.

Yamamoto R, Okamoto K, Yukiharu T, Kaneuchi M, Negishi H, Sakuragi N, et al. A study of risk factors for ovarian metastases in stage Ib-IIIb cervical carcinoma and analysis of ovarian function after a transposition. Gynecol Oncol. 2001;82:312–6.CrossRefPubMed

37.

Green DM, Whitton JA, Stovall M, Mertens AC, Donaldson SS, Ruymann FB, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol. 2002;187:1070–80.CrossRefPubMed

38.

Milgrom SA, Vargas HA, Sala E, Kelvin JF, Hricak H, Goodman KA. Acute effects of pelvic irradiation on the adult uterus revealed by dynamic contrast-enhanced MRI. Br J Radiol. 2013;86:20130334.CrossRefPubMedCentralPubMed

39.

Critchley HO, Wallace WH, Shalet SM, Mamtora H, Higginson J, Anderson DC. Abdominal irradiation in childhood; the potential for pregnancy. Br J Obstet Gynaecol. 1992;99:392–4.CrossRefPubMed

40.

Bath LE, Critchley HO, Chambers SE, Anderson RA, Kelnar CJ, Wallace WH. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br J Obstet Gynaecol. 1999;106:1265–72.CrossRefPubMed

41.

Holm K, Nysom K, Brocks V, Hertz H, Jacobsen N, Müller J. Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood. Bone Marrow Transplant. 1999;23:259–63.CrossRefPubMed

42.

Chiarelli AM, Marrett LD, Darlington GA. Pregnancy outcomes in females after treatment for childhood cancer. Epidemiology. 2000;11:161–6.CrossRefPubMed

43.

Signorello LB, Cohen SS, Bosetti C, Stovall M, Kasper CE, Weathers RE, et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst. 2006;98:1453–61.CrossRefPubMedCentralPubMed

44.

Lim K, Small Jr W, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys. 2011;79:348–55.CrossRefPubMed

45.

Marchiole P, Benchaib M, Buenerd A, Lazlo E, Dargent D, Mathevet P. Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent’s operation): a comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH). Gynecol Oncol. 2007;106:132–41.CrossRefPubMed

46.

Chan P, Dinniwell R, Haider MA, Cho YB, Jaffray D, Lockwood G, et al. Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: a cinematic-MRI point-of-interest study. Int J Radiat Oncol Biol Phys. 2008;70:1507–15.CrossRefPubMed

47.

Georg DKC, Hillbrand M, Dimopoulos J, Dimopoulos J, Pötter R. Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys. 2008;71:1272–8.CrossRefPubMed

48.

Marnitz S, Kohler C, Budach V, Neumann O, Kluge A, Wlodarczyk W, et al. Robotic radiosurgery: emulating brachytherapy in patients with locally advanced cervical carcinoma. Radiat Oncol. 2013;8:109.CrossRefPubMedCentralPubMed

49.

Neumann O, Kluge A, Lyubina O, Wlodarczyk W, Jahn U, Kohler C, et al. Robotic radiosurgery as an alternative to brachytherapy for cervical cancer patients. Strahlenther Onkol. 2014;190:538–45.CrossRefPubMed

Medicine Matters Oncology

Abstract